Cancer Stem Cells: The Origin of Cancer

Irving Weissman, professor of developmental biology at Stanford University Medical Center, addresses what cancer stem cells are, how they maintain themselves and why they may be resistant to some current treatments. Weissman also talks about the "don't eat me" signal and how it relates to the growth of certain types of cancer cells. Find out how Stanford scientists and clinicians are working to identifying cancer stem cells in many types of tumors and how they have used that information to develop new therapeutic strategies.

Early Diagnosis of Cancer: Imaging at the Molecular Level

Dr. Gambhir is the director of the Molecular Imaging Program at Stanford (MIPS), professor of Radiology and Bioengineering, and head of the Nuclear Medicine Division at Stanford University. He has over 20 years of experience in molecular imaging in both animal models and patients. He has an active laboratory, that focuses on developing molecular imaging assays in small animal models for translation into clinical applications. 

A life dedicated to science

The expression "a life dedicated to science" may seem a bit over the top for many, but it's spot on for German cancer researcher and Nobel laureate Harald zur Hausen. In the 1970s he first voiced his hypothesis that viruses could cause cancer, only to be mocked by older colleagues.

But his tenacity and single-mindedness saw him succeed in demonstrating the link between strains of the human papilloma virus (HPV) and cervical cancer. Now a vaccine has been developed to prevent women from contracting the disease. Tomorrow Today talks to the Nobel laureate and long-time researcher at the German Cancer Research Center, the DKFZ.

Adventures in the Cancer Genome

A very good lecture by Richard Wilson, Ph.D.
Washington University School of Medicine

NIH Intramural Sequencing Center 10th Anniversary Symposium
Genome Exploration by Large-Scale DNA Sequencing: Circa 2007 and Beyond

Cancer Biology and Cancer Medicine

Presentation by Nobel laureate Harold Varmus for the Stanford School of Medicine Medcast lecture series.

Nobel laureate Harold Varmus discusses the intersection of cancer biology and cancer medicine. Varmus, president of Memorial Sloan-Kettering Cancer Center in New York, earned his Nobel Prize for discovering retroviral oncogenes that can cause cancer. That work changed the way people thought about cancer: Rather than being a disease caused by environmental exposure, it could result from mutations in specific genes. Now, much cancer research and the search for therapeutics focus on genetic changes in cancer.

Telomerase and the Consequences of Telomere Dysfunction

Carolyn Widney "Carol" Greider (born April 15, 1961) is currently a molecular biologist at the Johns Hopkins University. She discovered the enzyme telomerase in 1984, when she was a graduate student of Elizabeth Blackburn at the University of California, Berkeley. Greider pioneered research on the structure of telomeres, the ends of the chromosomes. She was awarded the 2009 Nobel Prize for Physiology or Medicine, along with Blackburn and Jack W. Szostak of Boston, Massachusetts, for their discovery that telomeres are protected from progressive shortening by the enzyme telomerase

Welcome - Bienvenidos

We started this blog to disseminate information related to Experimental Oncology and Molecular Pathology

Iniciamos este blog con el fin de difundir información relacionada con la Oncologia Experimental y Patología Molecular

Alberto G. Menchen, M.D., Ph.D.

Julio A. Diaz-Perez, M.D., M.S.

Administrators - Administradores